EIKO Lifesciences

53.44
+1.36
(2.61%)
Market Cap
66.49 Cr
EPS
-4.99
PE Ratio
56.00
Dividend Yield
0.00 %
Industry
Chemicals
52 Week High
74.88
52 Week Low
42.00
PB Ratio
1.28
Debt to Equity
0.38
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
3,076.80
#1 1,56,500.68
77.81
12,522.60
#1 5.69
#1 1,747
9.04
74.72
2,995.30
88,788.13
77.59
13,221.50
-11.53
1,336
6.99
56.71
3,964.90
43,554.43
95.51
4,387.70
-25.09
435
57.50
57.90
2,019.30
27,541.85
39.75
7,757.90
-3.26
811
-51.46
53.75
465.90
23,000.61
41.50
4,227.40
0.66
411
34.98
57.29
4,373.50
21,680.98
80.90
2,120.90
0.37
271
7.18
60.67
4,634.20
20,059.43
#1 32.99
#1 13,843.30
-
563
-26.05
55.48
6,232.00
18,348.10
43.89
4,783.90
-13.69
324
#1 62.41
62.99
1,681.90
17,435.52
44.75
1,938.80
-8.77
323
21.85
62.43
445.20
16,139.39
43.02
6,380.70
-3.61
417
-62.90
62.93
Growth Rate
Revenue Growth
141.86 %
Net Income Growth
350.00 %
Cash Flow Change
-306.25 %
ROE
1,894.67 %
ROCE
996.13 %
EBITDA Margin (Avg.)
185.76 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Jun 2024
Sept 2024
Dec 2024
Revenue
1
1
1
1
2
4
3
1
1
1
11
8
8
Expenses
1
1
1
2
3
6
5
2
0
1
10
8
7
EBITDA
-0
-0
-0
-0
-0
-2
-1
-1
0
0
1
1
1
Operating Profit %
-9 %
-14 %
-14 %
-26 %
-18 %
-44 %
-42 %
-148 %
25 %
-6 %
4 %
5 %
9 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-0
-0
-0
-1
-1
-2
-2
-1
0
-0
1
0
1
Tax
-0
-0
0
-0
-0
-1
-0
-0
0
0
0
0
0
Net Profit
-0
-0
-0
-0
-0
-1
-1
-1
0
-0
0
0
0
EPS in ₹
-0.25
-0.26
-0.22
-0.58
-0.50
-1.87
-1.55
-1.08
0.17
-0.14
0.29
0.22
0.32

Balance Sheet

Balance Sheet
2018
2019
2020
Total Assets
11
9
12
Fixed Assets
2
2
2
Current Assets
6
4
5
Capital Work in Progress
0
0
0
Investments
3
2
0
Other Assets
6
6
10
Total Liabilities
11
9
12
Current Liabilities
5
4
9
Non Current Liabilities
1
0
2
Total Equity
6
5
1
Reserve & Surplus
2
1
-1
Share Capital
4
4
4

Cash Flow

Cash Flow
2017
2018
2019
2020
Net Cash Flow
0
0
-1
-0
Investing Activities
0
0
-0
-1
Operating Activities
0
0
0
-0
Financing Activities
0
0
-1
1

Share Holding

% Holding
Mar 2021
May 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Jan 2024
Mar 2024
Jun 2024
Sept 2024
Nov 2024
Dec 2024
Jan 2025
Mar 2025
Promoter
21.37 %
9.82 %
9.82 %
9.82 %
9.82 %
10.59 %
13.48 %
14.68 %
23.03 %
23.73 %
23.73 %
24.23 %
24.23 %
24.23 %
24.23 %
24.40 %
24.40 %
31.27 %
31.27 %
31.27 %
36.23 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
59.91 %
63.89 %
63.93 %
64.04 %
63.97 %
62.09 %
53.44 %
52.95 %
55.17 %
53.87 %
53.34 %
54.94 %
54.06 %
53.96 %
51.62 %
48.92 %
49.05 %
45.17 %
44.97 %
44.82 %
44.38 %
Others
18.72 %
26.29 %
26.26 %
26.14 %
26.21 %
27.32 %
33.08 %
32.36 %
21.80 %
22.40 %
22.93 %
20.83 %
21.71 %
21.80 %
24.15 %
26.68 %
26.55 %
23.56 %
23.76 %
23.91 %
19.39 %
No of Share Holders
298
381
380
389
420
537
585
809
1,142
1,874
2,155
2,722
2,637
2,728
3,000
2,938
3,140
3,199
3,456
3,565
3,336

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Submission Of Initial And Annual Disclosure As Per SEBI Circular- - Fund Raising By Issuance Issuance Of Debt Securities By Large Corporates7 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 28, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 28, 2025
Closure of Trading WindowMar 26, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 18, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 18, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 17, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 13, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 12, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 11, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 08, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 07, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 05, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 04, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 03, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 27, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 27, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 27, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 27, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 21, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 19, 2025
Newspaper PublicationFeb 14, 2025
Integrated Filing (Financial)Feb 12, 2025
Nil Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 12, 2025
Financial Results For Quarter And Nine Months Ended 31St December 2024Feb 12, 2025
Board Meeting Outcome for Outcome Of Board MeetinngFeb 12, 2025
Board Meeting Intimation for Meeting Of Board Of Directors Of The Company Is Scheduled To Be Held On Wednesday 12Th February 2025 To Consider And Approve Unaudited Financial Results (Standalone & ConsJan 24, 2025
Outcome Of The Meeting Of The Rights Issue Committee Of Board Of Directors Of Eiko Lifesciences Limited (Company) Held On Friday 24Th January 2025Jan 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 18, 2024
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsDec 18, 2024
Final Reminder Cum Forfeiture Call Notice To The Holders Of Partly Paid-Up Equity Shares (ISIN: IN9666Q01014), Who Have Not Paid The First And Final Call Money.Dec 17, 2024
Revised Outcome Of Right Issue Committee MeetingNov 25, 2024
Outcome Of The Meeting Of The Right Issue Committee Of Board Of Director Held On 25Th September, 2024Nov 25, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Nov 25, 2024
Board Meeting Intimation for Discussion On Final Reminder And Forfeiture Of The Partly Paid-Up Equity Shares On Which Call Money Has Not Been Received By The Company.Nov 19, 2024
Post-Offer Public AnnouncementNov 12, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 05, 2024
Announcement under Regulation 30 (LODR)-Diversification / DisinvestmentNov 05, 2024
Incorporation Of A Subsidiary CompanyNov 05, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 21, 2024
Unaudited Financials Results For September 2024Oct 19, 2024
Statement Of DeviationOct 19, 2024
Board Meeting Outcome for Financial ResultsOct 19, 2024
Board Meeting Intimation for The Unaudited Financial ResultsOct 11, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 11, 2024
Updates on Open OfferOct 08, 2024
Updates on Open OfferOct 07, 2024

Technical Indicators

RSI(14)
Neutral
48.85
ATR(14)
Less Volatile
3.55
STOCH(9,6)
Neutral
70.05
STOCH RSI(14)
Neutral
79.91
MACD(12,26)
Bullish
0.13
ADX(14)
Weak Trend
17.47
UO(9)
Bearish
48.15
ROC(12)
Downtrend And Accelerating
-2.58
WillR(14)
Neutral
-51.39